Cambridge researchers have discovered why living in a disadvantaged neighbourhood may be linked to an increase in an individual’s risk of dementia. In research published today, they show how it…
The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary endpoints were met at 16…
Prescription stimulant drugs such as Ritalin and Adderall are commonly used to treat attention deficit hyperactivity disorder (ADHD), including among children. In the United States, an estimated 3.5 million children…
Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to…
A new study published in the Journal of American Medical Association showed that children born to mothers 35 years of age or older had a 21–41% lower risk of developing…
Researchers have found in a new study that Upper Third Molars (UTM) positioned close to the sinus floor with mesial inclination were identified as the main risk factor for intra-operative…
Israel: A large-scale study published in Diabetes Care has shown that adolescents with autoimmune conditions face a significantly higher risk of developing type 1 diabetes (T1D) in adulthood. The study…
Spain: Researchers have found in a real-world cohort of patients with giant cell arteritis–associated aortitis, published in Arthritis Care & Research, that subcutaneous (SC) tocilizumab demonstrated slightly greater effectiveness than…
And other biotech news brought to you by The Readout newsletter
Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial